Bone Biologics updates ATM offering limit to $832,009 after $846k previously sold

Bone Biologics Corp

Filed prospectus supplement resetting ATM with H.C. Wainwright to max $832,009 in common shares.
Previously sold approximately $846,288 under September 27, 2024 prospectus supplement.
Shares offered under Sales Agreement dated September 27, 2024 with H.C. Wainwright & Co.
Legal opinion from Harter Secrest & Emery LLP on share legality filed as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.